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SOCS1/JAB Is a Negative Regulator
of LPS-Induced Macrophage Activation
gen-activated protein (MAP) kinase family and the Rel
family transcription factor NF-B (Akira et al., 2001; Med-
zhitov et al., 1998). However, since LPS still activates
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leads to NF-B and JNK/p38 activation in TLR4 signaling1Division of Molecular and Cellular Immunology
has been proposed (Kawai et al., 2001).Medical Institute of Bioregulation
Although the inflammatory response is critical to con-Kyushu University
trol the growth of pathogenic microorganisms (Cross et3-1-1 Maidashi, Higashi-ku
al., 1995; Eden et al., 1988; Hagberg et al., 1984; ShahinFukuoka 812-8582
et al., 1987), excessive cytokine production is harmful2 Division of Immunobiology
to the host and can even be fatal (Beutler et al., 1985;Research Institute for Biological Sciences
Danner et al., 1991). Chronic repeated exposure to endo-Science University of Tokyo
toxin (or LPS) causes a transient increase in the thresh-Noda 278-0022
old of endotoxin challenge (Beeson, 1947; Greisman etJapan
al.,1966; Ziegler-Heitbrock, 1995). This endotoxin toler-
ance is a negative feedback mechanism for protection
from endotoxic shock (Gustafson et al., 1995; HenricsonSummary
et al., 1990; Salkowski et al., 1998). Several factors are
involved in this process, including TLR4 downregulationBacterial lipopolysaccharide (LPS) triggers innate im-
(Nomura et al., 2000) and decreased NF-B activationmune responses through Toll-like receptor (TLR) 4. We
(Ziegler-Heitbrock et al., 1997; Goldring et al., 1998; Kas-show here that the suppressor of cytokine-signaling-1
tenbauer and Ziegler-Heitbrock, 1999). However, the un-(SOCS1/JAB) is rapidly induced by LPS and negatively
derlying mechanisms are largely unknown. Recently,regulates LPS signaling. SOCS1/ mice or SOCS1/
IRAK-M, which is restricted to monocytes/macrophages,mice with interferon- (IFN)-deficient background
is shown to be induced upon TLR stimulation and nega-were more sensitive to LPS-induced lethal effects than
tively regulate TLR signaling (Kobayashi et al., 2002).were wild-type littermates. LPS-induced NO2 synthe-
Recently, cytokine signal suppressors SOCS1 andsis and TNFproduction were augmented in SOCS1/
SOCS3 were found to be induced by LPS or CpG-DNAmacrophages. Furthermore, LPS tolerance, a protec-
stimulation in macrophages (Stoiber et al., 1999; Crespotion mechanism against endotoxin shock, was also
et al., 2000; Dalpke et al., 2001). We recently found thatstrikingly reduced in SOCS1/ cells. LPS-induced
SOCS3 plays an important role in the antagonistic effectI-B and p38 phosphorylation was upregulated in
of IL-10 against LPS-induced macrophage activationSOCS1/ macrophages, and forced expression of
(Berlato et al., 2002). SOCS1/ mice have been shownSOCS1 suppressed LPS-induced NF-B activation.
to die within 3 weeks after birth by severe inflammationThus, SOCS1 directly suppresses TLR4 signaling and
(Naka et al., 1998; Starr et al., 1998). However, in thesemodulates innate immunity.
mice, innate immunity was strongly enhanced, probably
due to hypersensitivity of SOCS1/ mice to inter-Introduction
feron- (IFN) (Alexander et al., 1999). SOCS1 interacts
with JAK tyrosine kinases and inhibits the kinase activ-
Bacterial LPS elicits a multitude of effects on the immune
ity, thereby suppressing the cytokine signal transduc-
system and can cause a fatal pathological effect. The
tion (Yasukawa et al., 2000). SOCS1 has been implicated
major target of LPS is macrophages and monocytes, in the hyporesponsiveness to cytokines such as IFN
and many of the biological effects of LPS are elicited after exposure of LPS to macrophages (Crespo et al.,
by secondary mediators, in particular, proinflammatory 2002). However, since SOCS1 has been reported to in-
agents such as tumor necrosis factor- (TNF) and reac- hibit several signaling pathways other than JAK/STATs,
tive oxygen and nitrogen species (Beutler et al., 1985; including TNF, insulin, and Vav (Morita et al., 2000;
Berczi., 1998; Tracey et al., 1987). Ligation of the TLR4- Kawazoe et al., 2001; De Sepulveda et al., 2000) and
MD2 complex induced by LPS results in recruitment of SOCS1-deficient mice exhibited systemic inflammatory
the adaptor molecule, MyD88, to the receptor cyto- response syndrome/multiple organ dysfunction syn-
plasmic domain, and then a serine/threonine kinase IL- drome-like severe inflammation (Naka et al., 1998, 2001;
1R-associated kinase (IRAK) that is subsequently re- Starr et al., 1998; Alexander et al., 1999; Marine et al.,
cruited becomes phosphorylated, dissociates from the 1999), we investigated the possibility that SOCS1 di-
receptor complex, and associates with TNF receptor- rectly downmodulates LPS signaling.
associated factor (TRAF)-6 (Poltorak et al. 1998; Akira In this paper, we found that SOCS1-deficient mice
et al., 2001; Medzhitov and Janeway, 2000). This subse- were more sensitive to LPS shock than wild-type lit-
quently leads to the activation of two different pathways termates. Furthermore, macrophages from SOCS1/
involving the c-Jun N-terminal kinase (JNK)/p38 mito- mice were more sensitive to endotoxin stimulation than
SOCS1/ macrophages. SOCS1/ cells have strikingly
impaired endotoxin tolerance, showing that SOCS1 neg-3 Correspondence: yakihiko@bioreg.kyushu-u.ac.jp
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Figure 1. Hypersensitivity of SOCS-1 KO Mice to LPS In Vivo
(A) Eight-week-old SOCS1/ and littermate SOCS1/ mice were intraperitoneally injected with 2 mg LPS for female (n  5) and 5 mg LPS
for male (n  5) mice. Lethality was observed over 120 hr after this challenge. The data are representative of two independent experiments
with similar results.
(B) Five- to eight-week-old IFN/SOCS1/ or IFN/SOCS1/ mice (n  8) were injected with 3 mg LPS, and lethality was observed.
Statistical analysis was performed using the Student’s t test, and the p values are shown.
(C) Five- to eight-week-old IFN/SOCS1/ or IFN/SOCS1/ mice (n  4) were injected with 3 mg LPS, and lethality was observed.
(D) Serum from IFN/SOCS1/ or IFN/SOCS1/ mice injected with the indicated amounts of LPS was collected at 1.5 hr after the
challenge, and TNF levels were measured by ELISA. Data show mean  SD for three mice from each group.
(E and F) Acute tubular necrosis in kidneys of IFN/SOCS1/ (E) and IFN/SOCS1/ (F) mice following challenge with LPS. Representative
histological sections with hematoxylin and eosin staining of kidneys from surviving mice that were sacrificed at 96 hr after LPS administration.
Magnification, 400.
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atively regulates TLR signaling. SOCS1 overexpression
suppressed LPS-induced I-B phosphorylation and
NF-B transcriptional activity. These data suggest that
SOCS1 plays an important role in the downregulation
of LPS signal transduction.
Results
Response of SOCS1-Deficient Mice to LPS
SOCS1 knockout (/) mice die within 3 weeks with
severe inflammation in almost all organs (Naka et al., 1998;
Starr et al., 1998). As shown previously, SOCS1/Rag2/
mice survived much longer, suggesting the role of T
cells in the lethality of SOCS1-deficient mice (Marine et
al., 1999). Consistent with these findings, we also found
that SOCS1/TCR/ double knockout mice also sur-
vived much longer than simple SOCS1 knockout mice
in specific pathogen-free (SPF) conditions (data not
shown). However, these mice die within 1 month with
severe inflammation under conventional conditions,
suggesting that the SOCS1/ genetic background is
much more sensitive to bacterial infection. To confirm
the involvement of SOCS1 in the sensitivity to bacterial
pathogen, we compared endotoxic shock between
SOCS1/ and SOCS1/ mice. SOCS1/ could not be
used since they were already sick within 1–2 weeks after
birth, and their macrophages might already be activated
by increased IFN concentration associated with inflam-
mation (Naka et al., 1998; Starr et al., 1998). Age- and
Figure 2. Hyperresponse to LPS of SOCS1-Deficient Macrophagessex-matched cohorts of mice were challenged intraperi-
Resident peritoneal macrophages from SOCS1/, SOCS1/,toneally with two different amounts of LPS and observed
IFN/SOCS1/, or IFN/SOCS1/ mice were stimulated withover 120 hr. As shown in Figure 1A, SOCS1/ mice
the indicated concentrations of LPS for 12 hr, and then the produc-
were more sensitive to LPS-induced lethality than were tion of NO2 and TNF was determined. Data are representative of
SOCS1/ mice. Since SOCS1/ mice exhibited no three independent experiments, with similar results.
signs of inflammation before LPS challenge, these data
led to the notion that SOCS1 levels modify the LPS
Enhanced LPS Signaling in SOCS1/ Macrophages
sensitivity.
Next, we examined LPS responses in macrophages from
SOCS1 has been characterized as a negative regula-
mice with various genetic backgrounds. As expected,
tor of interferon- (IFN) which is a potent activator of macrophages from SOCS1/ mice were already acti-
macrophages (Alexander et al., 1999; Naka et al., 2001; vated, and they produced nitric oxide (NO2) even with-Marine et al., 1999). To avoid the effect of interferon-, out LPS stimulation (data not shown). To avoid the effect
we used mice with IFN-deficient genetic background. of inflammation, we used SOCS1/ (Figure 2A) and
As reported, IFN/SOCS1/ mice survived much IFN/SOCS1/ (Figure 2B) mice. LPS-induced NO2
longer than SOCS1/ mice, and inflammatory lesions and TNF synthesis in macrophages from SOCS1/
were nil in all organs when we used these mice in experi- and IFN/SOCS1/ mice were 1.5- to 2-fold higher
ments (4–6 weeks postnatally) (Metcalf et al., 2002). As than those from control mice. Maximum levels of LPS-
shown in Figures 1B and 1C, IFN/SOCS1/ mice (B) induced NO2 and TNF in SOCS1/ macrophages
as well as IFN/SOCS1/ (C) were more sensitive were comparable to the levels of WT macrophages
to LPS than IFN/SOCS1/ mice. We also found treated with both LPS and IFN (data not shown). Macro-
that serum TNF levels after LPS injection were two phages from SOCS1/TCR/ mice were also more
times higher in IFN/SOCS1/ mice than in sensitive to LPS than were SOCS1/TCR/ macro-
IFN/SOCS1/ mice (Figure 1D). IFN/SOCS1/ phages (data not shown). Production of IL-6 and IL-1	
mice exhibited similar acute tubular necrosis in the kid- in response to LPS was also augmented in SOCS1/
ney as well as general signs of septic shock as found macrophages compared with SOCS1/ macrophages
in IFN/SOCS1/ mice (Figures 1E and 1F). However, (data not shown). SOCS1/ macrophages also pro-
tissue damage was more profound in IFN/SOCS1/ duced significantly higher levels of IL-6 and TNF in
mice than in IFN/SOCS1/ mice. Thus, SOCS1-defi- response to CpG-DNA than did wild-type macrophages
cient mice die not due to a specific abnormality caused (see Figure 4).
by SOCS1 deficiency but simply due to higher sensitivity To define the molecular mechanism of hyperrespon-
to LPS. These data suggest that SOCS1 defines LPS siveness to LPS in SOCS1/IFN/mice, we examined
the tyrosine phosphorylation of STAT1 and serine phos-sensitivity to IFN independently.
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secondary stimulation (Figure 4). As shown by previous
studies (Nomura et al., 2000), wild-type macrophages
showed reduced cytokine production in accordance
with a 24 hr incubation of LPS or CpG-DNA. Since pri-
mary LPS stimulation and CpG stimulation strongly re-
duced secondary CpG and LPS responses, respectively,
crosstolerance between TLR4 and TLR9 apparently oc-
curred in wild-type macrophages. However, SOCS1/
macrophages showed almost a complete lack of LPS
and CpG tolerance, and the cytokine levels produced
upon secondary LPS/CpG restimulation were not de-
creased as much as in restimulated wild-type macro-
phages (Figure 4). Although similar impaired tolerance
was observed in IRAK-M/ macrophages (Kobayashi
et al., 2002), it is striking that disruption of endotoxin
tolerance was observed even after 24 hr primary stimula-
tion in SOCS1/ macrophages, while IRAK-M/ mac-
rophages showed recovery of tolerance after 24 hr pri-
mary stimulation (Kobayashi et al., 2002). Therefore,
SOCS1 may be an important mechanism for the media-
tion of late endotoxin tolerance, which may operate after
IRAK-M functions.
Effect of Forced Expression of SOCS1
Figure 3. Hyperactivation of LPS Signaling Molecules in SOCS1- on LPS-Induced NF-B Activation
Deficient Peritoneal Macrophages Next, the role of SOCS1 in LPS signaling was examined
Phosphorylation of STAT1, I-B, JNK, and p38 in macrophages in in a macrophage cell line, Raw264.7. SOCS-1 is rapidly
response to LPS. Resident peritoneal macrophages from knockout induced by LPS as well as IFN treatment of Raw cellsmice were stimulated with 100 ng/ml LPS for the indicated periods,
(Figure 5A). Pretreatment of Raw cells with IFN for 2and then cell extracts (2  105 cells) were immunoblotted with the
hr (data not shown) or for 12 hr reduced the levels ofindicated antibodies.
phosphorylation of I-B induced by LPS (Figure 5B),
which suggested that SOCS1-induced by IFN sup-
presses LPS signaling. Therefore, we then stably ex-phorylation of I-B, p38, and JNK (Figure 3). LPS acti-
pressed SOCS1 in Raw cells by cDNA transfection. Asvates IKK	, resulting in the serine phosphorylation of
shown in Figure 5C, overexpression of SOCS1 resultedI-B, leading transcriptional activation of NF-B. JNK
in reduction of NO2 and TNF synthesis in Raw celland p38 are also activated through TRAF6. As an indirect
transformants expressing SOCS1. LPS-induced I-Beffect, probably autocrine/paracrine secretion of cyto-
phosphorylation was significantly reduced in thesekines, including IFN	 (Crespo et al., 2000; Toshchakov
transformants (Figure 5D). These data suggest thatet al., 2002), activates the JAK/STAT pathway. We also
SOCS1 inhibits LPS signaling by suppressing the TLR4-found that STAT1 was rapidly tyrosine phosphorylated
IKK	-I-B pathway.in macrophages in response to LPS (Figure 3). STAT1
Next, we examined the effect of transient overexpres-phosphorylation was slightly enhanced, and the phos-
sion of SOCS1 on LPS-induced NF-B activation usingphorylation of I-B, p38, and JNK was strongly en-
a reporter gene assay. SOCS1 overexpression sup-hanced in SOCS1/ macrophages compared with
pressed LPS-induced NF-B transcriptional activity incontrol SOCS1/ macrophages. These data strongly
Raw cells as well as in 293 fibroblastic cells expressingsupport our hypothesis that SOCS1 negatively regulates
both TLR4 and MD2 (Figures 6A and 6B). However,the LPS signaling pathway in macrophage activation
SOCS1 did not inhibit TNF-induced NF-B activationthrough both direct and indirect mechanisms.
in 293 cells (Figure 6A), suggesting that SOCS1 inhibits
the TLR-specific but not TNF-induced NF-B activa-
tion pathway. As reported previously, both TLR4 andSOCS1 Is Required for Endotoxin Tolerance
Our results showing that SOCS1 is a negative regulator MD2 were required for LPS-induced NF-B activation
in 293 cells (Shimazu et al., 1999) (Figure 6B). Usingof TLR signaling suggested that SOCS1 might be in-
volved in the induction of endotoxin tolerance. SOCS1 various mutants that we created previously (Yasukawa
et al., 1999), we found that the SH2 domain (R105E), KIRis also induced by TLR signaling (Dalpke et al., 2001 and
Figure 5A). We then determined the ability of SOCS1/ (kinase inhibitory region) (F59D), and C-terminal SOCS-
box of SOCS1 (dC40) were required for full suppressionmacrophages to develop endotoxin tolerance. SOCS1/
macrophages (IFN/ background) were first stimu- of NF-B (Figure 6C). Requirement of the SH2 domain
and KIR of SOCS1 suggests that an unidentified tyrosinelated with 100 ng/ml of LPS or 1 
M CpG-DNA (primary
LPS/CpG stimulation). CpG-DNA activates TLR9. After kinase pathway may be involved in the TLR4-mediated
NF-B activation pathway. Another possibility is that24 hr incubation, cells were restimulated with 100 ng/
ml of LPS or 1 
M CpG-DNA (second LPS/CpG stimula- SOCS1 may be able to inhibit TRAF6-downstream ser-
ine/threonine kinase such as TAK1 through KIR (Nino-tion), and IL-6 and TNF production was examined after
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Figure 4. Perturbed Endotoxin Tolerance in
SOCS1/ Macrophages
Endotoxin tolerance was induced in resi-
dent peritoneal macrophages from IFN/
SOCS1/ or IFN/SOCS1/ mice by pre-
activation with 100 ng/ml of LPS (L) (1st LPS)
or 1 
M CpG-DNA (C) (1st CpG). After 24 hr
incubation, cells were washed and restimu-
lated with 100 ng/ml of LPS (2nd LPS) or 1

M CpG-DNA (2nd CpG) for 24 hr, and then
IL-6 and TNF levels were determined by
ELISA. Examination of at least three different
mice from each group showed similar
findings.
miya-Tsuji et al., 1999). It has been demonstrated that and pathological effect of LPS. For example, NO2 syn-
thesis from STAT1/ as well as MyD88/macrophagesC-terminal SOCS-box is not required for the cytokine-
was reduced compared with those in wild-type macro-dependent STATs activation in vitro (Yasukawa et al.,
phages (Ohmori and Hamilton, 2001; Kawai et al., 1999).1999) but is necessary for full activity in vivo (Zhang
The promoter of inducible NO synthase (iNOS) has beenet al., 2001). Therefore, requirement of the SOCS-box
shown to possess STAT1 and NF-B binding sites, andsuggests that the mechanism for LPS signal suppres-
both seem to be required for full activation of this pro-sion by SOCS1 is different from that of cytokine-depen-
moter (Ganster et al., 2001). Our previous and presentdent JAK/STAT pathway. And SOCS1 also inhibited
results indicate that SOCS1 can negatively regulate bothNF-B activation by IRAK and TRAF6 but not by IKK	
STAT and NF-B pathways; one of the mechanisms ofwhen these molecules were overexpressed in 293 cells
macrophage inactivation by SOCS1 could be suppres-(Figure 6D). These data suggested that SOCS1 inhibits
sion of the JAK/STAT pathway indirectly activated bydownstream of TRAF6 and upstream of IKK	.
the autocrine/paracrine mechanism. The other inhibitoryWe examined the binding of SOCS1 with TRAF6, IRAK,
mechanism seems to be a direct effect on the TLR4IKK, and TAK1 by using Raw cells expressing Myc-
to IKK	 pathway, since SOCS1 suppressed LPS- andtagged SOCS1. However, we could not detect endoge-
TRAF6-induced NF-B activation, while phosphoryla-nous molecules in the immunoprecipitates of Myc-
tion of I-B, JNK, and p38 was enhanced in SOCS1/SOCS1. Since SOCS1 has an SH2 domain which should
macrophages. Our findings demonstrate, at the molecu-interact with tyrosine-phosphorylated molecules, there
lar level, that SOCS1 is an important negative regulatormay be unknown modulatory pathways of LPS signal
of LPS-induced macrophage activation, although wetransduction in which tyrosine kinases may be involved.
have not identified the target molecule of SOCS1 in theIdentification of the SOCS1 target molecule may reveal
TLR signaling pathways.a novel regulatory pathway of TLR4.
We have shown that SOCS1 plays an important role
in the establishment of endotoxin tolerance (Figure 4).
Discussion SOCS1 is induced by TLR stimulation and required for
not only LPS but also CpG-DNA tolerance, indicating
In this study, we have identified SOCS1 as a negative that SOCS1 is a key component of a feedback regulatory
regulator of TLR signaling in macrophage. It has been system of innate immunity. SOCS1, therefore, plays a
demonstrated that LPS as well as CpG-oligonucleotide critical role in the maintenance of homeostasis of the
induces SOCS1 and SOCS3 mRNA in macrophages and innate immune system. The molecular mechanism of
SOCS molecules postulated to inhibit further activation endotoxin tolerance is complicated, and probably multi-
of macrophages by IFN and/or other cytokines (Crespo ple mechanisms are involved. Simple overexpression of
et al., 2000, 2002; Dalpke et al., 2001). In the present SOCS1 in the macrophage cell line could not completely
paper, we describe evidence that SOCS1 can also di- suppress LPS-induced TNFa production and I-B phos-
rectly inhibit the LPS to NF-B signaling pathway in phorylation as shown in Figure 5. Therefore, we suspect
macrophages. Therefore, SOCS1 functions dually as a that SOCS1 may interact with an unidentified modulator
negative feedback regulator of TLR4. which is necessary for maintenance of LPS tolerance
There seem to be direct and indirect pathways for as well as LPS/CpG crosstolerance.
macrophage activation by LPS; one is the MyD88-IRAK- Recently, Takayanagi et al. reported that IFN induced
TRAF6-TAK1-IKK	 mediated phosphorylation of I-B ubiquitin-dependent rapid degradation of TRAF6, which
and TRAF6-mediated JNK, p38 activation, while the results in strong inhibition of the RANKL-induced activa-
other is an indirect activation of the JAK/STAT pathway tion of NF-B and JNK (Takayanagi et al., 2000). This
through autocrine/paracrine mechanisms (Crespo et al., study shows that there is crosstalk between the TRAF6-
2000; Toshchakov et al., 2002). Apparently, these two IKK pathway and the JAK/STAT pathway. Our present
study raises the possibility of a role of SOCS1 in thispathways are important for the macrophage activation
Immunity
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Figure 5. Suppression of LPS Response by SOCS1 in Raw Cells
(A) Raw cells were treated with 100 ng/ml LPS, 1000 unit/ml IFN, or both for indicated periods. Total RNA was isolated, and Northern hybridization
with SOCS1 or control G3PDH probes were carried out.
(B) Raw cells were pretreated with (IFN/LPS) or without (LPS) 1000 unit/ml IFN for 12 hr, then stimulated with 100 ng/ml LPS or 1000 unit/
ml IFN for the indicated periods. Phosphorylation of I-B was determined by immunoblotting with anti-phospho I-B specific antibody.
(C) NO2 and TNF production in response to LPS in parental Raw cells (Raw) and two independent transformations (Raw/SOCS1-1 and -2)
stably expressing SOCS1.
(D) Phosphorylation of LPS-induced I-B in Raw cell transformants. Raw cells and SOCS1 transformants (Raw/SOCS1-2) were stimulated
with 100 ng/ml LPS for the indicated periods. I-B phosphorylation was measured by immunoblotting. Data are representative of three
independent experiments with similar results.
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Figure 6. Suppression of LPS-Induced NF-
B Reporter Gene Activation by SOCS1 Over-
expression
(A) Raw cells were transfected with the indi-
cated amounts (
g) of SOCS1 plasmid and
NF-B reporter plasmid (2.0 
g), and control
lacZ plasmid (2.0 
g). After stimulation with
1 
g/ml LPS for 12 hr, luciferase activity and
	-galactosidase was measured. Relative lu-
ciferase activity normalized with lacZ activity
is shown.
(B) 293 cells were transfected without () or
with () TLR4 and MD2 (0.2 
g each), control
lacZ plasmid (0.1 
g), and the indicated
amounts of SOCS1 plasmid. After stimulation
with () or without () 1 
g/ml LPS for 12 hr,
luciferase activity was measured.
(C) Raw cells were transfected without () or
with wild-type (WT) and the indicated mutant
SOCS1 plasmids (2.0
g), and NF-B reporter
plasmid. After stimulation with () or without
() LPS for 12 hr, luciferase activity was mea-
sured. Equal expression levels of each
SOCS1 construct were confirmed by immu-
noblotting.
(D) 293 cells were transfected with indicated
TLR4 downstream molecules (0.5 
g IRAK,
0.1 
g TRAF6, and 0.5 
g IKK	) without (–)
or with the indicated amounts of SOCS1 plas-
mid. After 36 hr of transfection, luciferase ac-
tivity was measured and normalized with the
luciferase activity in the absence of SOCS1
plasmid.
Cell Culture and Stable Transfectioncrosstalk. Interestingly, IKK activation by TRAF6 has
RAW264.7 macrophages (obtained from RIKEN Cell Bank, Japan)been shown to be dependent on the TRAF6-mediated
were cultured in 10 cm dishes containing Dulbecco’s modified Ea-ubiquitination system (Deng et al., 2000). Since SOCS1
gle’s medium (Sigma) supplemented with 10% fetal bovine serum
contains the SOCS-box which recruits the Elongin B,C- (FBS). Approximately 6  105 cells/well were seeded into 6-well
Rbx1-Cul2 ubiquitination system (Kamizono et al., 2001), plates and transfected 24 hr later with the pcDNA3-myc-SOCS-1
and its mutant constructs (Yasukawa et al., 1999) using Fugeneubiquitination may be involved in SOCS1-mediated sup-
(Roche) according to the manufacturer’s instructions. Stable Rawpression of TRAF6-dependent IKK activation. Further
cell transformants were selected with 0.8 mg/ml G418. Differentstudy is under way to define the molecular mechanism
clones were then isolated and cultured in the presence of 0.8 mg/mlresponsible for the suppression of TRAF6 by SOCS1.
G418. In all the experiments, cells were stimulated with 100 ng/ml
of LPS. Transfection to 293 cells and luciferase assay were as de-
Experimental Procedures scribed (Yasukawa et al., 1999). The NF-B-responsive reporter
plasmid (p55Ig-luc), a generous gift from Dr. T. Fujita (The Tokyo
Mice and Peritoneal Macrophages Metropolitan Institute of Medical Science, Japan), contains three
SOCS1-deficient mice have been described elsewhere (Marine et copies of an NF-B binding site from the  light chain immunoglobu-
al., 1999). SOCS1/IFN / mice were generated by crossbreeding lin enhancer (Fujita et al., 1993). Recombinant plasmids for expres-
SOCS/ mice and mice with C57BL6 background homozygous sion of TRAF6 and IKK	 were kindly provided by Dr. J. Inoue
inactivation of the IFN gene, which were obtained from the Jackson (Waseda University, Japan). IRAK cDNAs were a generous gift from
Laboratory. All mice were housed in clean animal rooms with SPF Dr. T. Naka (Osaka University, Japan). Immunoblotting to detect
conditions. SOCS1/ and SOCS1/ littermate mice were chal- phosphorylated STAT1 and I-B was performed as described (Yasu-
lenged with LPS (Escherichia coli serotype O55:B5, Sigma) interperi- kawa et al., 1999). Anti-phospho-specific STAT1 antibody and I-B
toneally (IP), and the resulting lethality was observed until 120 hr were purchased from Cell Signaling Co.
after this challenge. Five male and five female mice were in each
experimental group.
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